Different PDE isoenzymes have been proposed as cancer therapeutic targets, but only PDE5 high levels have been found in different types of cancer (32) therefore, suggested as targets for inhibition, potentially with an anti-cancer outcome (33). The gene discussed is PDE5A; the disease is cancer.